NCT05690841

FocaL Mass Drug Administration for Vivax Malaria Elimination

RecruitingPHASE3INTERVENTIONAL

Trial Details

Start: 2024-10-14Est. Completion: 2027-05-01

Enrollment target: 7,530 participants

Locations

Contact

Malaria

Background: Malaria is a disease caused by parasites transmitted to people by mosquitoes. Around the world, there were …

Bethesda, United StatesEst. completion Nov 26, 2027

Vivax Malaria

The study will be an open-labelled randomized clinical trial to determine therapeutic efficacy. Note that this will not …

Phnom Penh, CambodiaCompleted Oct 1, 2024

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.